Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of generic entecavir 1 mg vs Baraclude 1 mg in healthy Thai volunteers (fasting, single-dose, crossover)
TCTR20200410003Phase 1Completed
- Sponsor
- Millimed
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of entecavir in Chronic Hepatitis B (CHB) (2 arms), sponsored by Millimed. Started Jul 2020; status: completed.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on TCTR20200410003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200410003.